Detection of Familial Mediterranean Fever attacks by using a connected activity tracker and assessment of impact of attacks to daily physical activities: a pilot study.
Activity tracking
Biosensor
Familial Mediterranean Fever
Wearable technology
Journal
Clinical rheumatology
ISSN: 1434-9949
Titre abrégé: Clin Rheumatol
Pays: Germany
ID NLM: 8211469
Informations de publication
Date de publication:
Jul 2019
Jul 2019
Historique:
received:
22
10
2018
accepted:
24
02
2019
revised:
05
02
2019
pubmed:
4
3
2019
medline:
18
12
2019
entrez:
4
3
2019
Statut:
ppublish
Résumé
The objective of this study was to assess the impact of Familial Mediterranean Fever (FMF) attacks on daily physical activity and detect FMF attacks using a connected activity tracker. Patients with FMF according to the Tel-Hashomer criteria were included in this prospective observational study. Attack-related data were collected weekly via phone call to avoid memory bias. Median steps in attack and attack-free days were calculated and compared using the Wilcoxon rank test. Sensitivity and specificity threshold for capturing attacks was set to two thirds of median steps per day in the whole observation period. Twelve patients participated in the study. The median age of patients was 26 (18-32) years, and 7 (58.3%) of them were male. Patients with attacks (n = 10) walked a median of 6990 (4552-11,531) steps per day in attack-free days, whereas this number decreased to a median of 1841 (590-4783) steps in attack days (p = 0.005). The activity tracker captured 42 of 45 attack days and 312 of 361 attack-free days. The cutoff value had 93% sensitivity and 86% specificity for capturing attacks. FMF attacks significantly impair the physical activity of patients. Activity tracking may be a reasonable method to document FMF attacks. This might prevent errors due to memory bias and help accurately identify and treat patients with FMF.
Identifiants
pubmed: 30826946
doi: 10.1007/s10067-019-04493-6
pii: 10.1007/s10067-019-04493-6
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
1941-1946Subventions
Organisme : Türkiye Bilimler Akademisi
ID : NA
Références
Heller H, Sohar E, Sherf L (1958) Familial Mediterranean fever. AMA Arch Intern Med 102(1):50–71
doi: 10.1001/archinte.1958.00260190052007
pubmed: 13558745
Sohar E, Gafni J, Pras M, Heller H (1967) Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med 43(2):227–253
doi: 10.1016/0002-9343(67)90167-2
pubmed: 5340644
Masters SL, Simon A, Aksentijevich I, Kastner DL (2009) Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease. Annu Rev Immunol 27:621–668. https://doi.org/10.1146/annurev.immunol.25.022106.141627
doi: 10.1146/annurev.immunol.25.022106.141627
pubmed: 19302049
pmcid: 2996236
Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, Migdal A, Padeh S, Pras M (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40(10):1879–1885. https://doi.org/10.1002/1529-0131(199710)40:10<1879::AID-ART23>3.0.CO;2-M
doi: 10.1002/art.1780401023
pubmed: 9336425
Aksentijevich ICM, Deng Z (1997) Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. The International FMF Consortium. Cell 90(4):797–807
doi: 10.1016/S0092-8674(00)80539-5
Chae JJ, Wood G, Masters SL, Richard K, Park G, Smith BJ, Kastner DL (2006) The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production. Proc Natl Acad Sci U S A 103(26):9982–9987. https://doi.org/10.1073/pnas.0602081103
doi: 10.1073/pnas.0602081103
pubmed: 16785446
pmcid: 1479864
Chae JJ, Aksentijevich I, Kastner DL (2009) Advances in the understanding of familial Mediterranean fever and possibilities for targeted therapy. Br J Haematol 146(5):467–478. https://doi.org/10.1111/j.1365-2141.2009.07733.x
doi: 10.1111/j.1365-2141.2009.07733.x
pubmed: 19466978
pmcid: 2759843
Bonfrate L, Scaccianoce G, Palasciano G, Ben-Chetrit E, Portincasa P (2017) A novel cluster of patients with Familial Mediterranean Fever (FMF) in southern Italy. Eur J Clin Investig 47(9):622–629. https://doi.org/10.1111/eci.12783
doi: 10.1111/eci.12783
Tufan A, Mercan R, Tezcan ME, Kaya A, Bitik B, Ozturk MA, Haznedaroglu S, Goker B (2013) Enthesopathy in patients with familial Mediterranean fever: increased prevalence in M694 V variant. Rheumatol Int 33(8):1933–1937. https://doi.org/10.1007/s00296-013-2669-4
doi: 10.1007/s00296-013-2669-4
pubmed: 23334425
Livneh A, Langevitz P, Zemer D, Padeh S, Migdal A, Sohar E, Pras M (1996) The changing face of familial Mediterranean fever. Semin Arthritis Rheum 26(3):612–627
doi: 10.1016/S0049-0172(96)80012-6
pubmed: 8989806
Babaoglu H, Varan O, Kucuk H, Turan A, Tufan A (2017) Osteitis as a manifestation of familial Mediterranean fever. Rheumatology (Oxford) 56(11):2035–2036. https://doi.org/10.1093/rheumatology/kex294
doi: 10.1093/rheumatology/kex294
Padeh S (2005) Periodic fever syndromes. Pediatr Clin N Am 52(2):577–609, vii. https://doi.org/10.1016/j.pcl.2005.01.005
doi: 10.1016/j.pcl.2005.01.005
Twig G, Livneh A, Vivante A, Afek A, Shamiss A, Derazne E, Tzur D, Ben-Zvi I, Tirosh A, Barchana M, Shohat T, Golan E, Amital H (2014) Mortality risk factors associated with familial Mediterranean fever among a cohort of 1.25 million adolescents. Ann Rheum Dis 73(4):704–709. https://doi.org/10.1136/annrheumdis-2012-202932
doi: 10.1136/annrheumdis-2012-202932
pubmed: 23505237
Goldstein RC, Schwabe AD (1974) Prophylactic colchicine therapy in familial Mediterranean fever. A controlled, double-blind study. Ann Intern Med 81(6):792–794
doi: 10.7326/0003-4819-81-6-792
pubmed: 4611296
Hentgen V, Grateau G, Kone-Paut I, Livneh A, Padeh S, Rozenbaum M, Amselem S, Gershoni-Baruch R, Touitou I, Ben-Chetrit E (2013) Evidence-based recommendations for the practical management of Familial Mediterranean Fever. Semin Arthritis Rheum 43(3):387–391. https://doi.org/10.1016/j.semarthrit.2013.04.011
doi: 10.1016/j.semarthrit.2013.04.011
pubmed: 23742958
Lidar M, Scherrmann JM, Shinar Y, Chetrit A, Niel E, Gershoni-Baruch R, Langevitz P, Livneh A (2004) Colchicine nonresponsiveness in familial Mediterranean fever: clinical, genetic, pharmacokinetic, and socioeconomic characterization. Semin Arthritis Rheum 33(4):273–282
doi: 10.1053/S0049-0172(03)00137-9
pubmed: 14978665
Lachmann HJ, Brogan PA (2016) Autoinflammation: when is familial Mediterranean fever ‘severe’? Nat Rev Rheumatol 12(5):256–258. https://doi.org/10.1038/nrrheum.2016.55
doi: 10.1038/nrrheum.2016.55
pubmed: 27108965
Gossec L, Guyard F, Leroy D, Lafargue T, Seiler M, Jacquemin C, Molto A, Sellam J, Foltz V, Gandjbakhch F, Hudry C, Mitrovic S, Fautrel B, Servy H (2018) Detection of flares by decrease in physical activity, collected using wearable activity trackers, in rheumatoid arthritis or axial spondyloarthritis: an application of Machine-Learning analyses in rheumatology. Arthritis Care Res (Hoboken). https://doi.org/10.1002/acr.23768
Kooiman TJ, Dontje ML, Sprenger SR, Krijnen WP, van der Schans CP, de Groot M (2015) Reliability and validity of ten consumer activity trackers. BMC Sports Sci Med Rehabil 7:24. https://doi.org/10.1186/s13102-015-0018-5
doi: 10.1186/s13102-015-0018-5
pubmed: 26464801
pmcid: 4603296
Steins D, Dawes H, Esser P, Collett J (2014) Wearable accelerometry-based technology capable of assessing functional activities in neurological populations in community settings: a systematic review. J Neuroeng Rehabil 11:36. https://doi.org/10.1186/1743-0003-11-36
doi: 10.1186/1743-0003-11-36
pubmed: 4007563
pmcid: 4007563
Ahanathapillai V, Amor JD, Goodwin Z, James CJ (2015) Preliminary study on activity monitoring using an android smart-watch. Healthc Technol Lett 2(1):34–39. https://doi.org/10.1049/htl.2014.0091
doi: 10.1049/htl.2014.0091
pubmed: 26609402
pmcid: 4611205
Erdmier C, Hatcher J, Lee M (2016) Wearable device implications in the healthcare industry. J Med Eng Technol 40(4):141–148. https://doi.org/10.3109/03091902.2016.1153738
doi: 10.3109/03091902.2016.1153738
pubmed: 27010250
Karadag O, Tufan A, Yazisiz V, Ureten K, Yilmaz S, Cinar M, Akdogan A, Erdem H, Ozturk MA, Pay S, Dinc A (2013) The factors considered as trigger for the attacks in patients with familial Mediterranean fever. Rheumatol Int 33(4):893–897. https://doi.org/10.1007/s00296-012-2453-x
doi: 10.1007/s00296-012-2453-x
pubmed: 22814791
Evenson KR, Sotres-Alvarez D, Deng YU, Marshall SJ, Isasi CR, Esliger DW, Davis S (2015) Accelerometer adherence and performance in a cohort study of US Hispanic adults. Med Sci Sports Exerc 47(4):725–734. https://doi.org/10.1249/MSS.0000000000000478
doi: 10.1249/MSS.0000000000000478
pubmed: 25137369
pmcid: 4333140